BÜHLMANN has launched the first Adalimumab trough level rapid test for serum samples. Easy to use, CE marked on the trusted Quantum Blue® technology platform, quantitative and highly correlating to ELISA methods. Time to result is 15 minutes. A significant advantage over time consuming batchwise work-up of ELISA methods.
With this new lateral flow product and together with the established Quantum Blue® Infliximab test, BÜHLMANN now exclusively offers the easy performance of therapeutic drug monitoring (TDM) for the most important TNF alpha antagonist biologic drugs used in IBD, inflammatory arthritis and other chronic inflammatory diseases. … read more